The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Immunohematology Market From 2026 To 2030?
The immunohematology market size has shown steady growth in recent years. It is projected to increase from $2.56 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. The market’s expansion in the past can be ascribed to several factors, including the increasing prevalence of blood disorders, a rising demand for safe blood transfusions, the development of blood banks, the growth in diagnostic laboratories, and advancements in hematology reagents.
The immunohematology market is projected to experience robust expansion over the coming years. It is set to reach a valuation of $3.27 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period is fueled by several factors, including advancements in analyzer technology, the integration of artificial intelligence into laboratory diagnostics, the increasing prevalence of precision medicine, the incorporation of digital health systems, and the broadening scope of blood screening initiatives. Key developments expected in this period encompass sophisticated blood typing methods, enhanced automation in immunohematology testing, tailored transfusion therapies, point-of-care immune diagnostic solutions, and the seamless integration of laboratory information systems.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp
Which Important Drivers Are Guiding The Immunohematology Market Growth?
The immunohematology market is anticipated to expand due to the increasing aging population in the future. This demographic trend signifies a rising percentage of older people in a society. Immunohematology plays a crucial role in meeting transfusion requirements for the elderly, guaranteeing the safe application of blood products, and aiding medical procedures for this demographic. For example, data from the US-based Population Reference Bureau in January 2024 indicates that the number of Americans aged 65 and above is projected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Their proportion within the total population is also forecasted to increase from 17% to 23% over the identical timeframe. Consequently, the aging population is a significant factor driving the expansion of the immunohematology market.
Which Segments Define The Immunohematology Market Segment Structure?
The immunohematology market covered in this report is segmented –
1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum
Which Trends Are Shaping Growth In The Immunohematology Market?
Leading companies in the immunohematology market are concentrating on developing innovative diagnostic solutions, such as soluble recombinant proteins designed to counteract the interference caused by the cancer therapy daratumumab. A soluble recombinant protein is one produced through recombinant DNA technology that maintains its proper folding and function in a soluble state within a host cell or solution, thereby facilitating its application in research and therapeutic fields. For instance, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, launched the Grifols sCD38 solution. Grifols’ sCD38 is the first soluble recombinant protein ever created. It was developed to address the interference from the cancer therapy daratumumab in critical blood transfusion compatibility testing. Specifically created for multiple myeloma patients, this innovative solution prevents daratumumab from attaching to CD38 proteins on red blood cells, ensuring precise outcomes for pre-transfusion tests. By facilitating a more efficient process for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and reduces delays in providing lifesaving transfusions.
Who Are The Established Players Within The Immunohematology Market?
Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.
Get The Full Immunohematology Market Report:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Which Region Dominates The Immunohematology Market By Market Share?
North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Immunohematology Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Browse Through More Reports Similar to the Global Immunohematology Market 2026, By The Business Research Company
Immunohematology Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Immunoassay Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
Immunodiagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model